Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects
Hardeep Singh Tuli,Vivek Kumar Garg,Jinit K Mehta,Ginpreet Kaur,Ranjan K Mohapatra,Kuldeep Dhama,Katrin Sak,Ajay Kumar,Mehmet Varol,Diwakar Aggarwal,Uttpal Anand,Jagjit Kaur,Ross Gillan,Gautam Sethi,Anupam Bishayee
DOI: https://doi.org/10.2147/OTT.S366630
IF: 4
2022-11-30
OncoTargets and Therapy
Abstract:Hardeep Singh Tuli, 1 Vivek Kumar Garg, 2 Jinit K Mehta, 3 Ginpreet Kaur, 3 Ranjan K Mohapatra, 4 Kuldeep Dhama, 5 Katrin Sak, 6 Ajay Kumar, 7 Mehmet Varol, 8 Diwakar Aggarwal, 1 Uttpal Anand, 9 Jagjit Kaur, 10 Ross Gillan, 11 Gautam Sethi, 12 Anupam Bishayee 11 1 Department of Biotechnology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to Be University), Mullana-Ambala, Haryana, India; 2 Department of Medical Lab Technology, University Institute of Applied Health Sciences, Chandigarh University, Mohali, Punjab, India; 3 Department of Pharmacology, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, Shri Vile Parle Kelavani Mandal, Narsee Monjee Institute of Management Studies, Mumbai, Maharashtra, India; 4 Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India; 5 Division of Pathology, Indian Council of Agricultural Research-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India; 6 NGO Praeventio, Tartu, Estonia; 7 Department of Botanical and Environmental Sciences, Guru Nanak Dev University, Amritsar, Punjab, India; 8 Department of Molecular Biology and Genetics, Faculty of Science, Mugla Sitki Kocman University, Mugla, Turkey; 9 Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 10 Centre of Excellence in Nanoscale Biophotonics, Graduate School of Biomedical Engineering, Faculty of Engineering, The University of New South Wales, Sydney, Australia; 11 College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, USA; 12 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Correspondence: Anupam Bishayee; Hardeep Singh Tuli, Email ; ; Cancer is a highly lethal disease, and its incidence has rapidly increased worldwide over the past few decades. Although chemotherapeutics and surgery are widely used in clinical settings, they are often insufficient to provide the cure for cancer patients. Hence, more effective treatment options are highly needed. Although licorice has been used as a medicinal herb since ancient times, the knowledge about molecular mechanisms behind its diverse bioactivities is still rather new. In this review article, different anticancer properties (antiproliferative, antiangiogenic, antimetastatic, antioxidant, and anti-inflammatory effects) of various bioactive constituents of licorice ( Glycyrrhiza glabra L.) are thoroughly described. Multiple licorice constituents have been shown to bind to and inhibit the activities of various cellular targets, including B-cell lymphoma 2, cyclin-dependent kinase 2, phosphatidylinositol 3-kinase, c-Jun N-terminal kinases, mammalian target of rapamycin, nuclear factor-κB, signal transducer and activator of transcription 3, vascular endothelial growth factor, and matrix metalloproteinase-3, resulting in reduced carcinogenesis in several in vitro and in vivo models with no evident toxicity. Emerging evidence is bringing forth licorice as an anticancer agent as well as bottlenecks in its potential clinical application. It is expected that overcoming toxicity-related obstacles by using novel nanotechnological methods might importantly facilitate the use of anticancer properties of licorice-derived phytochemicals in the future. Therefore, anticancer studies with licorice components must be continued. Overall, licorice could be a natural alternative to the present medication for eradicating new emergent illnesses while having just minor side effects. Keywords: licorice, cancer, apoptosis, cell cycle, angiogenesis, treatment, nano-delivery Since ancient times, humankind has strongly relied on medicinal plants and herbs in the treatment of diverse health conditions, including both benign neoplasms as well as malignant tumors. 1–3 Moreover, according to the World Health Organization (WHO) reports, about 80% of the worldwide population still depend on plant-derived drugs today, whereas several modern medicines have been originally isolated from medicinal plants. 4 It is especially the case for anticancer drugs, of which more than 60% of clinically-approved drugs are directly or indirectly derived from plant kingdom. 5,6 One of the oldest and most frequently described herbs in India, China, Southern Europe is licorice ( Glycyrrhiza. glabra L.), as its roots have been utilized for alleviating pain and treating gastrointestinal and respiratory symptoms already for centuries. 7–9 This plant is believed to have originate -Abstract Truncated-
oncology,biotechnology & applied microbiology